Form 4: Opko Health Sells Shares of GeneDx Holdings Corp.
SEC Form 4
Opko Health, a significant shareholder of GeneDx Holdings Corp., has sold a portion of its Class A Common Stock in a series of transactions.
Summary
- Opko Health, Inc., a 10% owner of GeneDx Holdings Corp., has reported the sale of Class A Common Stock.
- On August 15, 2024, Opko Health sold 39,824 shares at a weighted average price of $33.0832.
- On August 16, 2024, the company sold 50,000 shares at a weighted average price of $34.297.
- On August 19, 2024, another 50,000 shares were sold at a weighted average price of $34.4904.
- Following these transactions, Opko Health beneficially owns 2,646,972 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting share sales, indicating a neutral sentiment. It reflects transactions without expressing positive or negative views on the company's prospects.
Industry Context
This filing indicates activity by a major shareholder in GeneDx Holdings Corp., which is relevant to investors monitoring ownership changes and potential market impact.
Stakeholder Impact
- Shareholders may react to the news of Opko Health selling shares, potentially impacting the stock price.
- The sales could influence investor confidence depending on the perceived reasons behind the transactions.
Key Dates
| Date | Description |
|---|---|
| 08/15/2024 | Opko Health sold 39,824 shares of Class A Common Stock. |
| 08/16/2024 | Opko Health sold 50,000 shares of Class A Common Stock. |
| 08/19/2024 | Opko Health sold 50,000 shares of Class A Common Stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.